ENG
KOR
CONTACT
Our Company
About Us
R&D Centers
PBMS
Our Science
Biosimilar & First-in-Class Antibody
Development Pipeline
PBP1510
PBP1710
IDC001
Vaccine
R&D Technology
Investors
Stock Information
Listing Information
Stock Charts
Financial Information
Overview
Public Disclosures
Audited Financial Statements
Annual Report
Media
Newsroom
Events
PR Materials
Careers
INVESTORS
Annual Report
Annual Report
Date
Title and Content
24.Sep.2021
Announcement
Announcement Title: Announcement of Financial Result
Date: 24-Sep-2021
Report: Audited Financial Statements - IFRS
Description: Full year result for the Financial Year Ending 30 June 2021
16.Sep.2021
Business Report FY2021 (01/07/2020-30/06/2021)
